This chapter addresses the importance and quality risk-based implementation of supplier qualification. The goal is to provide guidance to the drug manufacturer in the "approach to select, assess, approve, and monitor suppliers of materials and services." Thus, in addition to a description of the process, the chapter includes a listing of tasks that the manufacturer faces and a list of risk-related items.
The draft chapter can be found on the USP website – which requires a one-time, free registration.
Comments on the draft will be accepted until November 30, 2021.
U.S. Pharmacopeia: Forum (Login)
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.